Literature DB >> 17558410

Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR.

Stella Maris Ranuncolo1, Jose M Polo, Jamil Dierov, Michael Singer, Tracy Kuo, John Greally, Roland Green, Martin Carroll, Ari Melnick.   

Abstract

Antibody specificity and diversity is generated in B cells during germinal center maturation through clonal expansion while they undergo class-switch recombination and somatic hypermutation. Here we demonstrate that the transcriptional repressor Bcl-6 mediates this phenotype by directly repressing ATR in centroblasts and lymphoma cells. ATR is critical in replication and DNA damage-sensing checkpoints. Bcl-6 allowed B cells to evade ATR-mediated checkpoints and attenuated the response of the B cells to exogenous DNA damage. Repression of ATR was necessary and sufficient for those Bcl-6 activities. CD40 signaling 'rescued' B cells from those effects by disrupting the Bcl-6 transcription-repression complex on the promoter of the gene encoding ATR. Our data demonstrate a transcriptional regulatory loop whereby Bcl-6 mediates the centroblast phenotype through transient silencing of ATR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558410     DOI: 10.1038/ni1478

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  125 in total

1.  BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.

Authors:  Javeed Iqbal; Paul N Meyer; Lynette M Smith; Nathalie A Johnson; Julie M Vose; Timothy C Greiner; Joseph M Connors; Louis M Staudt; Lisa Rimsza; Elaine Jaffe; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Wing C Chan
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

2.  A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.

Authors:  Wyndham H Wilson; Sin-Ho Jung; Pierluigi Porcu; David Hurd; Jeffrey Johnson; S Eric Martin; Myron Czuczman; Raymond Lai; Jonathan Said; Amy Chadburn; Dan Jones; Kieron Dunleavy; George Canellos; Andrew D Zelenetz; Bruce D Cheson; Eric D Hsi
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

3.  Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis.

Authors:  María Rodríguez Martínez; Alberto Corradin; Ulf Klein; Mariano Javier Álvarez; Gianna M Toffolo; Barbara di Camillo; Andrea Califano; Gustavo A Stolovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 4.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

5.  BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning.

Authors:  Daisuke Sakano; Akiko Kato; Nisarg Parikh; Kelly McKnight; Doris Terry; Branko Stefanovic; Yoichi Kato
Journal:  Dev Cell       Date:  2010-03-16       Impact factor: 12.270

6.  BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells.

Authors:  Himabindu Ramachandrareddy; Alyssa Bouska; Yulei Shen; Ming Ji; Angie Rizzino; Wing C Chan; Timothy W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

7.  Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface.

Authors:  Mingxing Teng; Scott B Ficarro; Hojong Yoon; Jianwei Che; Jing Zhou; Eric S Fischer; Jarrod A Marto; Tinghu Zhang; Nathanael S Gray
Journal:  ACS Med Chem Lett       Date:  2020-04-03       Impact factor: 4.345

8.  TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.

Authors:  Pilar M Dominguez; Hussein Ghamlouch; Wojciech Rosikiewicz; Parveen Kumar; Wendy Béguelin; Lorena Fontán; Martín A Rivas; Patrycja Pawlikowska; Marine Armand; Enguerran Mouly; Miguel Torres-Martin; Ashley S Doane; María T Calvo Fernandez; Matt Durant; Veronique Della-Valle; Matt Teater; Luisa Cimmino; Nathalie Droin; Saber Tadros; Samaneh Motanagh; Alan H Shih; Mark A Rubin; Wayne Tam; Iannis Aifantis; Ross L Levine; Olivier Elemento; Giorgio Inghirami; Michael R Green; Maria E Figueroa; Olivier A Bernard; Said Aoufouchi; Sheng Li; Rita Shaknovich; Ari M Melnick
Journal:  Cancer Discov       Date:  2018-10-01       Impact factor: 39.397

9.  LKB1 inhibition of NF-κB in B cells prevents T follicular helper cell differentiation and germinal center formation.

Authors:  Nicole C Walsh; Lynnea R Waters; Jessica A Fowler; Mark Lin; Cameron R Cunningham; David G Brooks; Jerold E Rehg; Herbert C Morse; Michael A Teitell
Journal:  EMBO Rep       Date:  2015-04-26       Impact factor: 8.807

10.  Checkpoint kinase 2 is required for efficient immunoglobulin diversification.

Authors:  Kathrin Davari; Samantha Frankenberger; Angelika Schmidt; Nils-Sebastian Tomi; Berit Jungnickel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.